Status:
COMPLETED
NT-proBNP and New Biomarkers in Patients With Dyspnea and/or Peripheral Edema
Lead Sponsor:
Universitätsmedizin Mannheim
Conditions:
Dyspnea
Peripheral Edema
Eligibility:
All Genders
18-90 years
Brief Summary
The objectives of this study are to: * Evaluate the sensitivity and specificity of NT-proBNP (N-terminal prohormone brain natriuretic peptide) and new biomarker measurements for the diagnosis of hear...
Detailed Description
Primary endpoint: * Sensitivity and specificity of biomarker measurements for discrimination of heart failure from dyspnea of other origin. Secondary endpoints: * Determination of Cut-off(s) * Disc...
Eligibility Criteria
Inclusion
- Age 18-90 years
- Dyspnea or/and peripheral edema
- Informed consent
Exclusion
- Renal insufficiency with creatinine \> 2.8mg/dl
- Anemia (hemoglobin \< 8.0mg/dl)
- Pregnancy
Key Trial Info
Start Date :
June 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00143793
Start Date
June 1 2005
End Date
December 1 2019
Last Update
August 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Faculty Mannheim, University of Heidelberg
Mannheim, Baden-Wurttemberg, Germany, 68167